ロード中...
TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
Osteoporosis is an osteolytic disorder commonly associated with excessive osteoclast formation. Transcriptional coactivator with PDZ-binding motif (TAZ) is a key downstream effector of the Hippo signaling pathway; it was suggested to be involved in the regulation of bone homeostasis. However, the ex...
保存先:
| 出版年: | Bone Res |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8275679/ https://ncbi.nlm.nih.gov/pubmed/34253712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41413-021-00151-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|